Icahn School of Medicine: Tisch Cancer Institute at Mount Sinai Medical Center is a clinical research site located in New York, New York, United States 10029.
Crixeo Health Trust Score: 65/100 (FAIR). This profile has not yet been claimed by the site owner.
Icahn School of Medicine: Tisch Cancer Institute at Mount Sinai Medical Center has participated in 4 clinical trials.
Therapeutic areas: Transitional Cell Carcinoma, Bladder Carcinoma, Urothelial Carcinoma.
Sponsors: Matthew Galsky, Dragonfly Therapeutics.
Trust Score: 65/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Icahn School of Medicine: Tisch Cancer Institute at Mount Sinai Medical Center has a Crixeo Trust Score of 65/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Icahn School of Medicine: Tisch Cancer Institute at Mount Sinai Medical Center has 4 clinical trials on record. Their work covers Transitional Cell Carcinoma, Bladder Carcinoma, Urothelial Carcinoma.
Icahn School of Medicine: Tisch Cancer Institute at Mount Sinai Medical Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.